Flolan: profile and news






Stocks to Watch, March 7: Albertson's, Kroger and Pixar Animation  06 Mar 2006
...in all territories outside the US At the same time, Myogen will be responsible for the US marketing and distribution of GlaxoSmithKline's Flolan, also used to ... - FOX News

Myogen Reports 2005 Results  06 Mar 2006
...year with ambrisentan ARIES-1 data expected in April, initiation of our darusentan Phase 3 program and launch of commercial operations for Flolan expected in ... - Business Wire (press release),

United Therapeutics foresees solid growth  Dec 8, 2005
Before United Therapeutics began marketing Remodulin, the treatment market was dominated by the drug Flolan, sold by the large British pharmaceutical firm ... - Business Gazette,

Rare condition affects girls lives  Dec 10, 2005
...case the tube came out. Should Eliana be without her supply of Flolan, even for a few minutes, she could die. Her family had one ... - Valencia County News Bulletin,

A Stock Pick to Add Power to Your Portfolio  Nov 16, 2005
GlaxoSmithKline's (GSK: sentiment, chart, options) Flolan delivers a synthetic chemical to the body that dilates the blood vessels in the lungs. ... - Schaeffers Research,

A father's fight: A Local man rings the opening bell at NASDAQ on ...  Nov 10, 2005
She said she is grateful for medicines like Thelin, which prevent her from having to use other sources of treatment like Flolan, which is a needle and tube ... - Woodlands Villager,

Viagra Spinoff Promising for Mild-to-Moderate PAH  Nov 17, 2005
For these patients with the most severe disease, Revatio would not be appropriate and Flolan (intravenous epoprostenol) should remain the gold standard, he ... - MedPage Today,

Resident with rare disease aims to educate, help others  Nov 25, 2005
Bohn is currently on Epoprostenol (or Flolan) which helps to open up her constricted lung blood vessels, and reduces high blood pressure in her lungs. ... - Thomaston Express,

United Therapeutics Leads the Charge  Sep 21, 2005
...recently as the mid-1990s, those who were diagnosed had only one option: GlaxoSmithKline's (GSK:NYSE - commentary - research - Cramer's Take) Flolan, which is ... - TheStreet.com (subscription),

COPD Link with PH is Rare, Say Doctors  Sep 15, 2005
Those include anticoagulants; calcium channel blockers, which relax and open blood vessels; epoprostenol (Flolan/a prostacyclin), which widens the arteries of ... - PH Neighborhood,

United Therapeutics Completes European Mutual Recognition for ...  Aug 10, 2005
..."Refilings in Ireland, Spain and the United Kingdom will be bolstered by interim data from the United States Phase IV Flolan® transition trial. ... - Yahoo News (press release)

United Therapeutics Profit Nearly Triples, to $12.2 Million  Aug 4, 2005
While it must be constantly pumped into the body, it doesn't have to be frozen and carried in a special backpack, as Glaxo's drug Flolan does. ... - Washington Post

United Therapeutics Reports Second Quarter 2005 Financial Results ...  Aug 2, 2005
Specifically, 13 of 14 patients (93%) in the Remodulin arm were able to successfully transition from Flolan® and complete the study without the need to ... - Yahoo News (press release)

FDA Sends Warning Letter to Actelion Over Tracleer Web Page  Jul 26, 2005
According to the Long-term Treatment section of the PI, “These estimates may be influenced by the presence of epoprostenol [Flolan] treatment, which was ... - PharmaLive.com (press release) <**results**>

Bill would fund research for PHT treatment  Jun 24, 2005
...year-old Maryland resident who suffers from PHT and must wear a device the size of a cassette-tape player that continuously pumps a drug called Flolan into his ... - Science Daily (press release)

Bill would fund research for PHT treatment  Jun 24, 2005
...year-old Maryland resident who suffers from PHT and must wear a device the size of a cassette-tape player that continuously pumps a drug called Flolan into his ... - Science Daily (press release)

Cancer and lung disease link means more treatment options  Jun 2, 2005
One such drug, Flolan, costs $100,000 a year per patient and must be pumped constantly into the body with equipment the patient carries around. ... - StarPhoenix,

Shirley woman with PH disorder credits miracles  Jun 3, 2005
The Flolan infusion drugs she is now on are working well, she said. When Morrill was diagnosed with primary PH, the outlook was bleak. ... - Bangor Daily News,

FDA Sends United Therapeutics Corp. Warning Letter Over Remodulin ...  Apr 26, 2005
The promotional materials that are the subject of this letter contain, among other things, claims comparing Remodulin to Flolan, another drug indicated for the ... - PharmaLive.com

Medtronic Announces Expanded Labeling for Its Model 407C General ...  Apr 19, 2005
...caution in patients with hepatic or renal impairment. Remodulin has not been studied in conjunction with Flolan(R) or Tracleer(R). - Business Wire,

France OKs United Therapeutics drug  Mar 8, 2005
Hadeed says. Remodulin's competitors include the pulmonary hypertension drug Flolan, which is marketed by GlaxoSmithKline. There ... - Raleigh Triangle Business Journal,

Long-Term Survival Using Tracleer for PH Faces Scrutiny  Mar 4, 2005
...a significant need for long-term observational studies of all the medications currently available for PH (epoprostenol (Flolan/GlaxoSmithKline), treprostinil ... - PH Neighborhood,

Nursing Director (D208  Feb 11, 2005
...arrhythmias. This unit is unique in that it specializes in the care of those patients with hypertension who are being treated with Flolan. ... - Kennebec Journal,

MD-Based United Therapeutics Gets Extension on Biggest Drug  Feb 25, 2005
It is an updated version of another, older Prostacyclin-based drug made by GlaxoSmithKline called Flolan, which requires a catheter for infusion. ... - RedNova.com,


Home | About | Cancers | Treatment | Medications
Copyright onconews.org 2005.
All Rights Reserved.
Google
 
Web onconews.org